14 Sep 2026 Avacta Appoints Mats Blom to the Board of Directors as Chair of Audit Committee Investors
08 Jul 2026 Avacta Appoints Healthcare Executive Patrick Vink as Deputy Chairman of the Board of Directors Investors
25 Jun 2026 Avacta Reports Platform-Validating Data with Faridoxorubicin during BIO International Conference Investors | Therapeutics
25 Jun 2026 Avacta Announces U.S. FDA Agreement on Pivotal Trial Design for AVA6000 in Patients with Salivary Gland Cancer Investors | Therapeutics